Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 27 M— — Research & development —— — Operating income -176 M— — Non-Operating Income, Total -47 M— — Interest expense, net of interest capitalized —3 M — Non-Operating Income, excl. Interest Expenses -46 M— — Unusual income/expense -1 M— — Pretax income 223 M— — Equity in earnings —— — Taxes -26 M19 M — Non-controlling/minority interest -120 M— — After tax other income/expense —— — Net income before discontinued operations -77 M-228 M — Discontinued operations —— — Net income -77 M-228 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 78 M-228 M — Basic earnings per share (Basic EPS) -0.52— — Diluted earnings per share (Diluted EPS) -0.52-1.6 — Average basic shares outstanding 133.74 M142.53 M — Diluted shares outstanding 133.87 M142.53 M — EBITDA —— — EBIT —— — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 182 M— —